Primary Melanoma Histologic Subtype: Impact on Survival and Response to Therapy.

MLA

Lattanzi, Michael, et al. “Primary Melanoma Histologic Subtype: Impact on Survival and Response to Therapy.” Journal of the National Cancer Institute, vol. 111, no. 2, Feb. 2019, pp. 180–88. EBSCOhost, https://doi.org/10.1093/jnci/djy086.

APA

Lattanzi, M., Lee, Y., Simpson, D., Moran, U., Darvishian, F., Kim, R. H., Hernando, E., Polsky, D., Hanniford, D., Shapiro, R., Berman, R., Pavlick, A. C., Wilson, M. A., Kirchhoff, T., Weber, J. S., Zhong, J., & Osman, I. (2019). Primary Melanoma Histologic Subtype: Impact on Survival and Response to Therapy. Journal of the National Cancer Institute, 111(2), 180–188. https://doi.org/10.1093/jnci/djy086

Chicago

Lattanzi, Michael, Yesung Lee, Danny Simpson, Una Moran, Farbod Darvishian, Randie H Kim, Eva Hernando, et al. 2019. “Primary Melanoma Histologic Subtype: Impact on Survival and Response to Therapy.” Journal of the National Cancer Institute 111 (2): 180–88. doi:10.1093/jnci/djy086.